Please use this identifier to cite or link to this item: http://hdl.handle.net/11054/1992
Full metadata record
DC FieldValueLanguage
dc.contributorLivori, Adamen_US
dc.contributorLevkovich, B.en_US
dc.contributorOqueli, Ernestoen_US
dc.date.accessioned2022-10-25T02:19:11Z-
dc.date.available2022-10-25T02:19:11Z-
dc.date.issued2022-
dc.identifier.govdoc01915en_US
dc.identifier.urihttp://hdl.handle.net/11054/1992-
dc.description.abstractBackground: Advances in percutaneous coronary intervention (PCI) have contributed to increased survival following acute coronary syndromes (ACS). Optimal medical therapy (OMT)—ACE inhibitor, aspirin, P2Y12 inhibitor, statin, beta blocker—is paramount for secondary prevention of Major Adverse Cardiovascular Events (MACE). Studies have shown real-world adherence for cardiovascular medications post-ACS can be as low as 50%. New interventions are required. Aim: Does patient participation in a cardiology pharmacist clinic following PCI in ACS improve 12-month adherence to OMT? Method: Retrospective matched cohort study utilising Melbourne Interventional Group data, compared before and after implementation of post-PCI pharmacist telehealth clinic. Patients were consulted by the pharmacist at one month, three months and twelve months’ post PCI. Matching criteria included age, sex, presence of left ventricular dysfunction and type of ACS. Secondary endpoints include changes to 4-point MACE. Results: 473 patients yielded 78 matched pairs (n=156). Analysis of adherence to OMT at twelve months demonstrated an absolute increase in adherence to OMT by 13% (31% vs 44%, p=0.038). Furthermore, sub-optimal medication therapy (three or less ACS medications at twelve months) reduced by 23% (31% to 8%, p=0.004). MACE at twelve months reduced by 23% (31% vs 8%, p=0.004). Conclusion: The pharmacist clinic demonstrated a novel intervention delivered via telehealth significantly improved adherence at to OMT at twelve months; a demonstrated contributor to mortality and morbidity outcomes for post ACS patients. Primary and secondary outcomes in the intervention group were both statistically significant. Pharmacist led follow up is both cost effective and improves patient outcomes.en_US
dc.description.provenanceSubmitted by Gemma Siemensma (gemmas@bhs.org.au) on 2022-08-17T01:10:36Z No. of bitstreams: 1 Livori PCI clinicpptx.pptx: 2243960 bytes, checksum: 7b79c30d1e6326f9e7c9963248a70c30 (MD5)en
dc.description.provenanceApproved for entry into archive by Gemma Siemensma (gemmas@bhs.org.au) on 2022-10-25T02:19:11Z (GMT) No. of bitstreams: 1 Livori PCI clinicpptx.pptx: 2243960 bytes, checksum: 7b79c30d1e6326f9e7c9963248a70c30 (MD5)en
dc.description.provenanceMade available in DSpace on 2022-10-25T02:19:11Z (GMT). No. of bitstreams: 1 Livori PCI clinicpptx.pptx: 2243960 bytes, checksum: 7b79c30d1e6326f9e7c9963248a70c30 (MD5) Previous issue date: 2022en
dc.titleAssessment of telehealth cardiology pharmacist clinic in improving therapy adherence following acute coronary syndrome and PCI.en_US
dc.typeConferenceen_US
dc.type.specifiedPresentationen_US
dc.bibliographicCitation.conferencedate11-14 Augusten_US
dc.bibliographicCitation.conferencename70th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealanden_US
dc.bibliographicCitation.conferenceplaceGold Coasten_US
dc.subject.healththesaurusPCIen_US
dc.subject.healththesaurusTELEHEALTHen_US
dc.subject.healththesaurusPHARMACYen_US
dc.subject.healththesaurusCARDIOLOGYen_US
Appears in Collections:Research Output

Files in This Item:
File Description SizeFormat  
Livori PCI clinicpptx.pptx2.19 MBMicrosoft Powerpoint XMLView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.